Research Papers

25 of 756 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Trends and Hotspots in Global Radiomics Research: A Bibliometric Analysis.
Zhang M; Wang Y; Lv M; Sang L; Wang X; Yu Z; Yang Z; Wang Z; Sang L.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Patient Cranial Angle and Intrafractional Stability in CyberKnife Robotic Radiosurgery: A Retrospective Analysis.
Kang CL; Huang YY; Chen YR; Tsai SH; Huang CC; Huang YJ.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The Effect of Dose Enhancement in Tumor With Silver Nanoparticles on Surrounding Healthy Tissues: A Monte Carlo Study.
Çağlar M; Eşitmez D; Cebe MS.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Elevated INHBA Promotes Tumor Progression of Cervical Cancer.
Wu Z; Chen J; Yang L; Sun K; Jiang Q; Dong F; Lu W; Chen R; Chen Y.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Decanoylcarnitine Inhibits Triple-Negative Breast Cancer Progression via Mmp9 in an Intermittent Fasting Obesity Mouse.
Tang Y; Chen S; Wang S; Xu K; Zhang K; Wang D; Feng N.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Proton Therapy in Breast Cancer: A Review of Potential Approaches for Patient Selection.
Wu XY; Chen M; Cao L; Li M; Chen JY.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma.
Jiang JY; Yao FY; Liu J; Wang XL; Huang B; Zhong FM; Wang XZ.
Technol Cancer Res Treat (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Extracellular Vesicles Obtained From Lung Adenocarcinoma Cells Cultured Under Intermittent Hypoxia Induce M2 Macrophage…
Liu Y; Lu M; Liu F; Xu G; Feng C; Chen Y; Cai D; Sun H; Zeng Y; Xie J; Ma W; Gao X.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Multileaf Collimator Modeling and Commissioning for Complex Radiation Treatment Plans Using 2-Dimensional (2D) Diode Ar…
Guo J; Zhu M; Zeng W; Wang H; Qin S; Li Z; Tang Y; Ying B; Sang J; Ji M; Meng K; Hui Z; Wang J; Zhou J; Zhou Y; Huan J.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
HTATIP2 Overexpression was Associated With a Good Prognosis in Gastric Cancer.
Park SY; Park JH; Yang JW; Jung EJ; Ju YT; Jeong CY; Kim JY; Park T; Park M; Lee YJ; Jeong SH.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoi…
Li J; Liu J; Xia W; Yang H; Sha W; Chen H.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Research Progress on Structure-Activity Relationship of 1,8-Naphthalimide DNA Chimeras Against Tumor.
Zhang HY; Han LL; Wu HY; Xu XX; Yu MB; Chen GY; Qi XL.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Suppression of NBS1 Upregulates CyclinB to Induce Olaparib Sensitivity in Ovarian Cancer.
Zhong A; Cheng CS; Lu RQ; Guo L.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Attention Connect Network for Liver Tumor Segmentation from CT and MRI Images.
Shao J; Luan S; Ding Y; Xue X; Zhu B; Wei W.
Technol Cancer Res Treat (Unknown)
Published: 2024
4/6 Transparent
Code Funding Declared
Clinical Characteristics and Outcomes of AIDS-Related Burkitt Lymphoma in China: A Retrospective Single-Center Study.
Liu R; Zhao H; Xiao G; Tao Y; Tang X; Feng L; Liao B; Liu B; Guan J; Li L; Chen Z; He H; You H.
Technol Cancer Res Treat (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Trans…
Assefa D; Melaku T; Alemu S.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression.
Liu H; Wei Z; Shi K; Zhang Y; Li J.
Technol Cancer Res Treat (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Radiomic Models Predict Tumor Microenvironment Using Artificial Intelligence-the Novel Biomarkers in Breast Cancer Immu…
Lin G; Wang X; Ye H; Cao W.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Accuracy and Feasibility of Synthetic CT for Lung Adaptive Radiotherapy: A Phantom Study.
Zhao R; Wang X; Wei H.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Efficacy and Safety of Dual Anti-HER2 Blockade and Docetaxel With or Without Carboplatin as Neoadjuvant Regimen for Tre…
Lin B; Fan J; Liu F; Wen Y; Li J; Gao F; Zhang Y; Feng G; Du X; Chen W.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
3D-US and CBCT Dual-guided Radiotherapy for Postoperative Uterine Malignancy: A Primary Workflow Set-up.
Li Y; Gong Z; Liu M; Li H; Gao H; Guo C; Yu L; Zhu C; Sun Z; Sun L; Xu H; He X.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Global Trends and Prospects Regarding Exosomes in Cancer Immunology Research Over the Past 10 Years.
Xia D; Wu R; Wang S; Chen G; Lu Y; Zhao L.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Dosimetric Comparison of Postmastectomy Radiotherapy Plans for Synchronous Bilateral Breast Cancer, Including Regional …
Wu X; Huang J; Lin X; Zhang X; Lu H; Sun W; Duan S; Shi J; Huang X.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Integrated Predictors by Propensity Scoring With Tumor Markers and Plasma Levels of microRNA-21-5p, IL-17, and IL-10 Co…
Machida M; Ambo M; Mishina R; Hada N; Tachibana F; Yamashita M; Konda A; Tsuji K.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Integrating Therapeutic Ultrasound With Nanosized Drug Delivery Systems in the Battle Against Cancer.
Moradi Kashkooli; Jakhmola A; Ferrier GA; Hornsby TK; Tavakkoli JJ; Kolios MC.
Technol Cancer Res Treat (Unknown)
Published: 2023
3/6 Transparent
Funding Declared